Quick Heal Technologies Limited , a prominent player in the cybersecurity software sector, has announced the departure of its Chief Executive Officer (CEO), Vishal Salvi. The company confirmed that Salvi's resignation became effective on August 31, 2025, following an earlier announcement made on July 9, 2025.

Resignation Details

Vishal Salvi, who also held the position of Key Managerial Personnel within the company, cited his intention to pursue an alternative career path as the reason for his departure. This move marks a significant change in Quick Heal's leadership structure.

Regulatory Compliance

In adherence to regulatory requirements, Quick Heal Technologies has provided the necessary disclosures to the stock exchanges. The company has complied with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency in its corporate governance practices.

Company's Response

Quick Heal has attached Salvi's resignation letter to their stock exchange filing, demonstrating their commitment to keeping shareholders and the market informed. The company's prompt disclosure aligns with the best practices in corporate communication and regulatory compliance.

Looking Ahead

As Quick Heal Technologies navigates this transition in leadership, the cybersecurity industry will be watching closely to see how the company adapts and who will step into the role vacated by Vishal Salvi. The departure of a key executive often signals a period of change for a company.

While the immediate impact of this change on Quick Heal's operations and market position remains to be seen, the company's adherence to proper disclosure procedures indicates a commitment to maintaining investor trust during this transition period.

Stakeholders and industry observers will likely be keen to learn about Quick Heal's succession plans and any potential shifts in corporate strategy that may follow this leadership change.

Quick Heal Technologies Limited , a prominent player in the cybersecurity industry, has announced significant changes to its board composition. The company recently disclosed these changes in a filing to the stock exchanges, highlighting the transition in key leadership roles.

Independent Director Completes Term

Mr. Bhushan Gokhale, who has served as an Independent Director for Quick Heal Technologies, completed his term on August 11, 2025. Mr. Gokhale's tenure spanned a period of five years, during which he made valuable contributions to the company's governance structure.

Changes in Committee Roles

Following Mr. Gokhale's retirement, the company has undergone a reshuffle in its committee compositions:

1. Stakeholders Relationship Committee: Mr. Gokhale, who previously held the position of Chairman of the Stakeholders Relationship Committee, has stepped down from this role.

2. Audit Committee: Additionally, Mr. Gokhale has also ceased to be a member of the Audit Committee.

New Appointments

To ensure continuity and strengthen its corporate governance, Quick Heal Technologies has made the following appointments:

• Ms. Amita Mirajkar has been appointed as the new Chairman of the Stakeholders Relationship Committee.
• Ms. Mirajkar will also serve as a member of the Audit Committee.

These new appointments took effect on August 12, 2025, immediately following Mr. Gokhale's retirement.

Regulatory Compliance

The company has made these disclosures in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Quick Heal Technologies has also provided detailed information as required under SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/ 0155 dated November 11, 2024.

This board restructuring reflects Quick Heal Technologies' commitment to maintaining strong corporate governance practices and ensuring a smooth transition in its leadership roles. As the company moves forward, these changes are expected to bring fresh perspectives to its strategic decision-making processes.